TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Thern Medicine AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 1,797 | 1,215 | 243 |
Financial expenses | 33 | 22 | 0 |
Earnings before taxes | 138 | 199 | -85 |
EBITDA | 105 | 231 | -84 |
Total assets | 532 | 410 | 108 |
Current assets | 407 | 282 | 68 |
Current liabilities | 525 | 337 | 123 |
Equity capital | 7 | 73 | -131 |
- share capital | 51 | 47 | 49 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 1.3% | 17.8% | -121.3% |
Turnover per employee | 898 | 608 | 122 |
Profit as a percentage of turnover | 7.7% | 16.4% | -35.0% |
Return on assets (ROA) | 32.1% | 53.9% | -78.7% |
Current ratio | 77.5% | 83.7% | 55.3% |
Return on equity (ROE) | 1971.4% | 272.6% | 64.9% |
Change turnover | 495 | 980 | -207 |
Change turnover % | 38% | 416% | -46% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.